Clincosm LogoSign in Get a demo

pyruvate kinase deficiency

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Canada, Japan (Mitapivat)

Not yet recruiting
  • Pyruvate Kinase Deficiency
  • Anemia, Hemolytic
  • Hamilton, Ontario, Canada
  • +3 more
Mar 9, 2023

Pyruvate Kinase Deficiency, Pyruvate Kinase Deficiency Anemia, Anemia Trial in Worldwide

Recruiting
  • Pyruvate Kinase Deficiency
  • +3 more
    • Boston, Massachusetts
    • +4 more
    Aug 5, 2022

    Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Worldwide (Placebo, AG-348)

    Completed
    Has Results
    • Pyruvate Kinase Deficiency
    • Anemia, Hemolytic
    • Little Rock, Arkansas
    • +45 more
    May 20, 2022

    Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Worldwide (AG-348)

    Completed
    Has Results
    • Pyruvate Kinase Deficiency
    • Anemia, Hemolytic
    • Oakland, California
    • +18 more
    Dec 14, 2021

    Pyruvate Kinase Deficiency Trial in Stanford, Madrid (RP-L301)

    Recruiting
    • Pyruvate Kinase Deficiency
    • RP-L301
    • Stanford, California
    • +2 more
    Sep 22, 2021

    Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

    Not yet recruiting
    • Pyruvate Kinase Deficiency
    • +10 more
    • Blood Draw
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 21, 2021

    Pyruvate Kinase Deficiency Epidemiological Study (PIECE)

    Unknown status
    • Pyruvate Kinase Deficiency
      • Pembroke Pines, Florida
        Intervent Clinical Research Center
      Nov 23, 2020

      Pyruvate Kinase Deficiency, Congenital Non-Spherocytic Hemolytic Anemia Trial in Worldwide

      Completed
      • Pyruvate Kinase Deficiency
      • Congenital Non-Spherocytic Hemolytic Anemia
        • Phoenix, Arizona
        • +29 more
        May 20, 2020